`____________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`
`
`
`APPLE INC.
`Petitioner
`v.
`MAXELL, LTD.
`Patent Owner
`___________
`
`
`
`Case No. IPR2020-00407
`U.S. Patent No. 6,748,317 B2
`____________
`
`
`PETITIONER APPLE INC.’S PRELIMINARY REPLY
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`
`I. Fintiv’s and NHK’s Focus on the Trial Date Is Misplaced as a Basis
`for the Board’s Exercise of Its Discretion ............................................................ 1
`II. The Fintiv Factors Favor Institution ............................................................. 7
`Factor 1 – Evidence exists that a stay may be granted if IPR is
`instituted: .......................................................................................................... 7
`Factor 2 – Litigation will continue after the FWD: ........................................ 7
`Factor 3 – The Court has little substantive investment: ................................. 8
`Factor 4 – There is little to no overlap between the IPR and
`Litigation: ......................................................................................................... 9
`Factor 5 – Parties in Litigation and IPR: .......................................................10
`Factor 6 – Other Circumstances:....................................................................10
`
`
`
`
`
`
`
`
`
`
`
`Petitioner disputes the statutory authority of the Board to deny institution
`
`under NHK/Fintiv. Even if such authority exists, Fintiv is inapplicable here.
`
`I.
`
`Fintiv’s and NHK’s Focus on the Trial Date Is Misplaced as a Basis
`for the Board’s Exercise of Its Discretion
`
`The NHK/Fintiv factors are based on the Board’s belief that it has broad
`
`discretion under § 314(a) to deny institution. Apple Inc. v. Fintiv, Inc., IPR2020-
`
`00019, Paper 15, at 11 (PTAB May 13, 2020). In Fintiv, the Board ruled that
`
`“considerations of efficiency and fairness … can serve as an independent reason to
`
`apply discretion to deny institution.” Id. This is misplaced. An agency “literally has
`
`no power to act … unless and until Congress confers power upon it.” La. Pub. Serv.
`
`Comm’n v. FCC, 476 U.S. 355, 374 (1986). “[A]n agency’s power is no greater than
`
`that delegated to it by Congress.” Lyng v. Payne, 476 U.S. 926, 937 (1986). The
`
`express language of 35 U.S.C. § 314(a) limits the Director’s decision on institution
`
`to whether “there is a reasonable likelihood that the petitioner would prevail with
`
`respect to at least 1 of the claims challenged.” This is a substantive analysis on the
`
`patentability of the claims— not a subjective assessment of “fairness” as proposed
`
`by Fintiv. The fact that § 314(a) is phrased as a prohibition on institution “unless”
`
`the “reasonable likelihood” standard is met indicates other statutory provisions
`
`impose additional limits on institution. Section 314(a) is not an invitation to create
`
`other, non-statutory grounds for denial.
`
`The exclusive grounds for denying institution are within the statute. Section
`
`
`
`1
`
`
`
`313 states a preliminary response to a petition “sets forth reasons why no inter partes
`
`review should be instituted based upon the failure of the petition to meet any
`
`requirement of this chapter.” 35 U.S.C. § 313 (emphasis added). If Congress had
`
`wanted the Patent Owner and the Board to rely on non-statutory reasons to deny
`
`review beyond “any requirement of this chapter,” it would have said so. There is no
`
`statutory provision that empowers discretion based on the overlap with litigation or
`
`on the basis of “efficiency and fairness.” Fintiv, Paper 15, at 12. The guidance set
`
`forth in NHK/Fintiv is beyond the scope of the Board’s statutory authority and, if
`
`not, is arbitrary and capricious. 5 U.S.C. §§ 706(2)(A) and (C).
`
`Moreover, even if the Director had authority to adopt the NHK/Fintiv factors,
`
`the Board has no authority to do so outside of the Director doing so through notice-
`
`and-comment rulemaking. “Congress organized the PTO with certain powers
`
`delegated to the Director, and others delegated to the Board.” Facebook, Inc. v.
`
`Windy City Innovations, LLC, 953 F.3d 1313, 1341 (Fed. Cir. 2020) (additional
`
`views of Prost, C.J., and Plager and O’Malley, JJ.). To the Board, Congress
`
`delegated merely the power to “conduct each inter partes review.” 35 U.S.C. §
`
`316(c); see Facebook, 953 F.3d at 1341 (Congress “delegated the power to
`
`adjudicate IPRs to the Board”). That “is not a delegation of authority to issue
`
`adjudicative decisions interpreting statutory provisions of the AIA.” Facebook, 953
`
`F.3d at 1340. When it comes to the task of “setting forth the standards for the
`
`
`
`2
`
`
`
`showing of sufficient grounds to institute a review under section 314(a)” and
`
`“establishing and governing inter partes review,” Congress vested that power in the
`
`Director. And he must exercise it through notice-and-comment rulemaking: “The
`
`Director shall prescribe regulations.” 35 U.S.C. §§ 316(a)(2) & (4). Further,
`
`Congress did not authorize the Director “to engage in any rulemaking other than
`
`through the mechanism of prescribing regulations,” including “adjudication.”
`
`Facebook, 953 F.3d at 1340, 1342. Even if Congress had, the Director cannot use
`
`precedential opinions to establish rules for the institution of IPRs in circumvention
`
`of the requirement of notice-and-comment rulemaking by the Director. Cf. N.L.R.B.
`
`v. Bell Aerospace Co. Div. of Textron, 416 U.S. 267, 294 (1974) (Board could
`
`announce new rules through adjudication because it “had both adjudicative and rule-
`
`making powers”).
`
`The Fintiv factors also are misplaced. First, Congress explicitly allows
`
`petitioners one year to file IPR petitions after service of a complaint. Congress did
`
`not choose to set the bar backwards from a scheduled trial date—a date not known
`
`for months after a suit begins, and which may vary and change.
`
`Particularly in cases where a plaintiff asserts multiple patents (ten in this case),
`
`the certainty a 1-year window provides is essential to meet the deadline. Trial-based
`
`timing forces defendants to forego an IPR or hastily file an IPR without opportunity
`
`to develop the record. See Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007).
`
`
`
`3
`
`
`
`Second, the Board’s focus on overlap with trial directly undermines the AIA’s
`
`objectives of improving patent quality. “Congress, concerned about overpatenting
`
`and its diminishment of competition, sought to weed out bad patent claims
`
`efficiently.” Thryv, Inc. v. Click-to-Call Techs., LP, __ U.S. __ (Apr. 20, 2020) (slip
`
`op., at 8); see also Foster v. Hallco Mfg. Co., 947 F.2d 469, 474 (Fed. Cir. 1991).
`
`Congress intended for IPRs to “serve as a less-expensive alternative to the courtroom
`
`litigation.” 157 Cong. Rec. S1352 (March 8, 2011) (Sen. Udall).
`
`To achieve this, Congress gave litigants “access to the expertise of the Patent
`
`Office on questions of patentability” and noted IPRs should be “the preferred method
`
`of examination because a panel of experts is more likely to reach the correct
`
`decision.” Id; see also 157 Cong. Rec. S5319 (Sept. 6, 2011) (Sen. Kyle). There is
`
`no doubt Congress was aware of the overlap between litigation and IPRs. The
`
`Supreme Court also was aware of the overlap and noted it was inherent to Congress’s
`
`design. Cuozzo Speed Techs., LLC v. Lee, 136 S. Ct. 2131, 2146 (2016) (“This
`
`possibility, however, has long been present in our patent system, which provides
`
`different tracks—one in the Patent Office and one in the courts—for the review and
`
`adjudication of patent claims. [] These different evidentiary burdens mean that the
`
`possibility of inconsistent results is inherent to Congress’s regulatory design.”).
`
`There simply is no basis to use overlap as a basis of denial.
`
`
`
`4
`
`
`
`Third, the NHK/Fintiv factors’ focus on a trial date ignores that IPR
`
`proceedings not only may stop trials on invalid patents, but also may eliminate the
`
`injustice of infringement verdicts rendered on invalid patents.1 The Federal Circuit
`
`has embraced this significant benefit. In Fresenius v. Baxter, it explained that a final,
`
`post-grant decision of invalidity renders a patent void ab initio and, unless final,
`
`overrides any corresponding district court finding. 721 F.3d 1330 (Fed. Cir. 2013).
`
`Fourth, looking speculatively at a trial date ignores the practical realities of
`
`shifting litigation dockets. Over 40% of cases have their initial trial dates continued
`
`by more than four months, some even longer.2 Post-trial motions may continue for
`
`months after the verdict. Ironically, the trial date in NHK was extended more than
`
`eight months. If the Board had instituted, the FWD would have issued several
`
`months before the trial. And that assumes a case normally progresses to trial. In cases
`
`where a motion to transfer venue is filed, over 51% of those requests were granted
`
`in 2019 (Ex. 1044, Transfer Statistics) and, once transferred, a new trial date is set,
`
`and the new judge will have a different view on stays pending IPRs.
`
`Fintiv’s focus on trial also allows so-minded courts to artificially influence
`
`institution. For example, J. Albright (W.D. Tex.) recently denied a motion to stay
`
`pending IPR pre-institution and sua sponte shortened the time to trial such that the
`
`
`1 (Ex. 1055, stay statistics, showing stays granted 74+% of the time).
`2 (Ex. 1043, trial date statistics).
`
`
`
`5
`
`
`
`new trial date now precedes the FWD’s expected statutory deadline. The Board’s
`
`guidelines should not allow manipulation. (Ex. 1049, minute entry moving trial to
`
`5/10/21); (Ex. 1050, scheduling order showing trial previously in July 2021); see
`
`also IPR2020-00140 (filing date of 5/14/2020, with anticipated FWD on 5/14/2021).
`
`Fifth, economies exist well after trial. Post-trial events may take years.
`
`Cancelling claims through IPR prevents this. In Fresenius, the trial concluded, an
`
`appeal was filed, and while the case was pending on remand, the Patent Office found
`
`all asserted claims invalid, thus avoiding more appeals. This highlights the error in
`
`thinking a fast-approaching trial is more “efficient” and will “save resources.” 3
`
`Sixth, considering a trial date as a threshold of institution ignores Congress’s
`
`desire to obtain a district court stay based on institution. See, e.g., IOENGINE, LLC
`
`v. PayPal Holdings, Inc., 2019 U.S. Dist. LEXIS 141545, at *9-10 (D. Del. Aug. 21,
`
`2019) (J. Bryson); 157 Cong. Rec. S1363 (daily ed. Mar. 8, 2011) (Sen. Schumer).
`
`A perverse situation emerges where a district court sets a relatively short initial time
`
`to trial, the Board denies an IPR based on that trial date, and the district court then
`
`denies a stay. This self-fulfilling prophecy will deprive significant numbers of
`
`petitioners what is otherwise available to them by statute.
`
`
`3 The judge denied multiple requests to stay the case, which became moot after the
`
`PTO canceled the claims, thus wasting significant resources. Id. at 1335.
`
`
`
`6
`
`
`
`Finally, by focusing on a putative trial date, the Board encourages patent
`
`owners to forum shop. If the mere possibility of a district court trial before an FWD
`
`is a de facto bar on institution, the PTAB’s doors will be closed to any defendant in
`
`a jurisdiction that is “fast,” and the public interest in eliminating invalid patents will
`
`be harmed. No statute supports allowing litigation venue to carry such sway.
`
`The Fintiv Factors Favor Institution
`
`II.
`Factor 1 – The Court will revisit a stay if an IPR is instituted: Apple
`
`moved to stay the underlying litigation. (Ex. 1045, District Court Docket, Dkt. 239).
`
`The Court denied but noted that a renewed motion after institution may be granted.
`
`(Ex. 1052, District Court Docket, Dkt. 298). This favors Apple because institution
`
`will increase the chance of a stay being granted. “If [the Board] were to institute trial
`
`and reach a final written decision [], we would likely simplify, if not resolve entirely,
`
`the invalidity issues the district court must address.” Cisco Sys., Inc. v. Ramot at Tel
`
`Aviv Univ. Ltd., IPR2020-00122, Paper 14, Dissent at 5.
`
`Factor 2 – Trial may be moved based on this Board’s decision: Trial is
`
`currently scheduled for October 26, 2020,4 and the FWD is expected by August 12,
`
`2021. But “the consideration of the ‘proximity’ of the trial date cannot be as simple
`
`as comparing two dates on the calendar and determining which is first.” Id. at 7.
`
`
`4 This date assumes there will be no changes due to COVID-19, which is unlikely.
`
`
`
`7
`
`
`
`“Obviously, if the litigation is stayed [upon a renewed motion] … the trial date in
`
`[October] of this year will necessarily be pushed back, and will occur after the
`
`issuance of [the Board’s] final written decision.” Id. And if the IPRs are successful,
`
`there will be no need for a trial and significant resources will be saved for all parties.
`
`Moreover, the deadlines in this case highlight the problems with focusing on
`
`trial. Maxell filed suit alleging infringement of 10 patents on March 15, 2019.
`
`(Petition, Paper 1, at 8-10). To guarantee FWDs before the current trial date, Apple
`
`would have needed to file all 10 of its petitions in April 2019, less than one month
`
`after it was sued. Requiring Apple to locate art for 10 different patents and 132
`
`possibly-asserted claims, and then prepare and file petitions in less than 30 days is
`
`completely unreasonable. See 157 Cong. Rec. S5429 (Sept. 8, 2011) (Sen. Kyl)
`
`(“High-technology companies … are often sued by defendants asserting multiple
`
`patents with large numbers of vague claims …. [I]t is important that the section
`
`315(b) deadline afford defendants a reasonable opportunity to identify and
`
`understand the patent claims that are relevant to the litigation.”)
`
`Factor 3 – The Court has little substantive investment: This factor should
`
`only favor denial if the forward-looking investment from the Court outweighs the
`
`investment done in the past. Cisco, IPR2020-00122, Paper 14, Dissent at 8. The
`
`Board must consider “the investment that will be required of the parties and the
`
`court” as the cases moves to trial. No briefing on dispositive issues or pre-trial efforts
`
`
`
`8
`
`
`
`have begun, and the Court has not made any rulings on the merits. This outweighs
`
`the limited work the Court has done on Markman, which does not favor denial. The
`
`Board’s own rules contemplate taking up an IPR after a district court has construed
`
`the claims. Id. at FN.3; 37 C.F.R. § 42.100(b). Nor did the litigation give Apple a
`
`tactical advantage. Maxell did not substantively respond to Apple’s invalidity
`
`contentions, and Apple could not have used any substantive insight in its IPR filings.
`
`Factor 4 – There is little to no overlap between the IPR and Litigation:
`
`As the legislative history makes clear, Congress was not concerned with overlap.
`
`Congress expected the PTAB to provide its expertise and even provided a different
`
`standard (rather than the clear and convincing standard in district courts) to evaluate
`
`patents. Instead, Congress anticipated overlap and provided estoppel in the district
`
`court to account for any such overlap. Thus, overlap between the litigation favors
`
`institution because it will ultimately create simplification and efficiencies through
`
`the estoppel. Id. at 10. And, if instituted, the overlap will be resolved, or Petitioner
`
`will be constrained by estoppel. Thus, “overlapping issues are unlikely, and
`
`Congress’ goal of providing an efficient alternative venue for resolving questions of
`
`patentability is achieved.” Cisco, IPR2020-00122, Paper 14, Dissent, at 10.
`
`Regardless, there are differences between the IPR and litigation. First, this
`
`IPR challenges different claims based on different art. Maxell asserts only claims 1
`
`and 17 in the litigation. Ex. 1053, Maxell’s Final Election of Asserted Claims, at 1.
`
`
`
`9
`
`
`
`The Petition challenges claims 1-3, 5, 10-15, 17, and 18. Second, this IPR presents
`
`different grounds. Ground 1 advances Hayashida in view of the knowledge of a
`
`PHOSITA and Ground 2 advances Hayashida in view of Abowd. Paper 1, 5. Neither
`
`of these grounds remains in the litigation. There, two of the four remaining
`
`obviousness grounds rely on NavTalk as a base reference, a product not at issue in
`
`the IPR. Ex. 1047, Apple’s Final Election of Prior Art, 2. A third remaining obvious
`
`ground combines Hayashida with Maruyama, which is not in the IPR. Id. The final
`
`obvious ground in the litigation relies on the CyberGuide system modified pursuant
`
`to Hayashida. Id. But this ground is materially different from Ground 2 in the IPR.
`
`The CyberGuide reference relied upon in the litigation is system prior art, only some
`
`pertinent details of which are described in the Abowd publication. Also, Ground 2 in
`
`the IPR proposes Hayashida modified in view of Abowd’s teachings, whereas the
`
`litigation ground depends on CyberGuide as a base reference that is modified in view
`
`of Hayashida. Accordingly, not only will the motivations to combine be different,
`
`but the proposed modified system will be significantly different.
`
`Factor 5 – Parties in Litigation and IPR: This factor is only relevant when
`
`the district court defendant and the petitioner are unrelated. In cases such as this, the
`
`factor is neutral. Cisco, IPR2020-00122, Paper 14, Dissent at 11.
`
`Factor 6 – Other Circumstances: See Section I. Additionally, this case does
`
`not involve serial or parallel petitions, which also favors institution.
`
`
`
`10
`
`
`
`III. Maxell Misinterprets Abowd’s “Do Not Circulate” Stamp
`To establish the public availability of Abowd, Petitioner submitted a
`
`declaration from librarian expert, Jacob Munford. Ex. 1009. Mr. Munford discussed
`
`Appendix AB01, which is a scanned copy of the Abowd reference contained within
`
`a bound collection of Wireless Networks. Ex. 1009, ¶¶ 6-7. AB01 and its MARC
`
`record, AB02, demonstrate that the University of Pittsburgh began cataloguing
`
`Wireless Networks in 1995 and sent a collection of issues (including the October
`
`1997 issue containing Abowd) to a book bindery between January and March of
`
`1998—all of which occurred more than one year before the priority date. Id.
`
`Without support, Maxell argues that a “Do Not Circulate” stamp on AB01
`
`“indicate[s] that it was not meant for public use.” Paper 6, 47. The specific
`
`transaction Mr. Munford conducted with AB01, however, demonstrates that
`
`Maxell’s interpretation cannot be correct. Ex. 1054, Supp. Munford Dec. Namely,
`
`Mr. Munford requested AB01 via the library’s public catalog. Id. He was permitted
`
`to directly access AB01 in a special collections room and photocopy without
`
`restriction. Consistent with common practice in library sciences to preserve archived
`
`references, the “Do Not Circulate” stamp simply means the reference cannot be
`
`removed from the premises, not that it is inaccessible to the public. Id.
`
`
`
`
`
`
`
`
`
`11
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`ERISE IP, P.A.
`
`BY: /s/Adam P. Seitz
`
`
`Adam P. Seitz, Reg. No. 52,206
`Jennifer C. Bailey Reg. No. 52,583
`Robin A. Snader, Reg. No 66,085
`7015 College Blvd., Suite 700
`Overland Park, KS 66211
`P: (913) 777-5600
`F: (913) 777-5601
`adam.seitz@eriseip.com
`jennifer.bailey@eriseip.com
`
`
`
`Paul R. Hart, Reg. No. 59,646
`5299 DTC Blvd., Suite 1340
`Greenwood Village, CO 80111
`P: (913) 777-5600
`F: (913) 777-5601
`paul.hart@eriseip.com
`
`
`
`
`
`ATTORNEYS FOR PETITIONER
`APPLE INC.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`12
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE ON PATENT OWNER
`UNDER 37 C.F.R. § 42.6
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on June 4, 2020
`the foregoing Petitioner Apple Inc.’s Preliminary Reply was served via electronic
`filing with the Board and via Electronic Mail on the following practitioners of record
`for Patent Owner:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Robert G. Pluta (rpluta@mayerbrown.com)
`Maxell-Apple-Service@mayerbrown.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Adam P. Seitz
`
`
`
`Adam P. Seitz, Reg. No. 52,206
`
`
`
`
`ATTORNEY FOR PETITIONER
`
`13
`
`